David Vidal

690 total citations
28 papers, 379 citations indexed

About

David Vidal is a scholar working on Health Informatics, Epidemiology and Dermatology. According to data from OpenAlex, David Vidal has authored 28 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health Informatics, 7 papers in Epidemiology and 4 papers in Dermatology. Recurrent topics in David Vidal's work include Artificial Intelligence in Healthcare and Education (7 papers), Nonmelanoma Skin Cancer Studies (4 papers) and Quality and Safety in Healthcare (3 papers). David Vidal is often cited by papers focused on Artificial Intelligence in Healthcare and Education (7 papers), Nonmelanoma Skin Cancer Studies (4 papers) and Quality and Safety in Healthcare (3 papers). David Vidal collaborates with scholars based in Spain, United States and United Kingdom. David Vidal's co-authors include Agustı́n Alomar, L. Puig, A. Alomar, Montserrat Gilaberte, Xavier Matías‐Guiu, Antonia Vila, A. Alomar, María A. Barnadas, María Teresa Fernández‐Figueras and A. Laíz and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Dermatology and Journal of the American Medical Informatics Association.

In The Last Decade

David Vidal

23 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Vidal Spain 12 148 130 53 45 41 28 379
Lara Valeska Maul Switzerland 12 81 0.5× 108 0.8× 295 5.6× 101 2.2× 9 0.2× 49 537
Melanie Hagen Germany 9 46 0.3× 36 0.3× 50 0.9× 97 2.2× 7 0.2× 33 482
Elizabeth Quigley United States 9 149 1.0× 142 1.1× 500 9.4× 46 1.0× 16 0.4× 19 683
Mara Giavina‐Bianchi Brazil 13 94 0.6× 132 1.0× 200 3.8× 48 1.1× 24 0.6× 30 391
Yudai Kaneda Japan 12 62 0.4× 12 0.1× 86 1.6× 73 1.6× 67 1.6× 84 847
Hazel Κ. Bell United Kingdom 11 109 0.7× 144 1.1× 111 2.1× 13 0.3× 66 503
Juliana Berk-Krauss United States 8 60 0.4× 102 0.8× 262 4.9× 42 0.9× 2 0.0× 17 463
Van C. Willis United States 11 67 0.5× 5 0.0× 102 1.9× 259 5.8× 22 0.5× 28 825
Pietro Sollena Italy 11 177 1.2× 174 1.3× 218 4.1× 56 1.2× 32 451
Ana‐Maria Forsea Romania 10 158 1.1× 236 1.8× 367 6.9× 38 0.8× 29 580

Countries citing papers authored by David Vidal

Since Specialization
Citations

This map shows the geographic impact of David Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vidal more than expected).

Fields of papers citing papers by David Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vidal. The network helps show where David Vidal may publish in the future.

Co-authorship network of co-authors of David Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of David Vidal. A scholar is included among the top collaborators of David Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vidal. David Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasan, Alifia, David Vidal, Manesh R. Patel, et al.. (2025). Aligning AI principles and healthcare delivery organization best practices to navigate the shifting regulatory landscape. npj Digital Medicine. 8(1). 278–278.
2.
Vidal, David, David S. McClintock, Mark A. Lifson, et al.. (2024). Embedding Internal Accountability Into Health Care Institutions for Safe, Effective, and Ethical Implementation of Artificial Intelligence Into Medical Practice: A Mayo Clinic Case Study. SHILAP Revista de lepidopterología. 2(4). 574–583. 5 indexed citations
3.
Malik, Momin M., et al.. (2024). AImedReport: A Prototype Tool to Facilitate Research Reporting and Translation of Artificial Intelligence Technologies in Health Care. SHILAP Revista de lepidopterología. 2(2). 246–251.
4.
Sendak, Mark, Alifia Hasan, Mark A. Lifson, et al.. (2024). Empowering US healthcare delivery organizations: Cultivating a community of practice to harness AI and advance health equity. PLOS Digital Health. 3(6). e0000513–e0000513. 1 indexed citations
5.
Hasan, Alifia, Katherine C. Kellogg, William Ratliff, et al.. (2024). Development and preliminary testing of Health Equity Across the AI Lifecycle (HEAAL): A framework for healthcare delivery organizations to mitigate the risk of AI solutions worsening health inequities. SHILAP Revista de lepidopterología. 3(5). e0000390–e0000390. 22 indexed citations
6.
Boag, William, Alifia Hasan, Henry David Jeffry Hogg, et al.. (2023). Organizational Governance of Emerging Technologies: AI Adoption in Healthcare. 1396–1417. 19 indexed citations
7.
Pencina, Michael, et al.. (2023). Implementing quality management systems to close the AI translation gap and facilitate safe, ethical, and effective health AI solutions. npj Digital Medicine. 6(1). 218–218. 15 indexed citations
8.
Vidal, David & Fernando Alfageme. (2019). Punción aspiración con aguja fina y biopsia con aguja gruesa ecoguiada en dermatología: un paso adelante. Actas Dermo-Sifiliográficas. 110(9). 707–709. 1 indexed citations
9.
Vidal, David, Ricardo Ruíz‐Villaverde, Fernando Alfageme, et al.. (2016). Use of high frequency ultrasonography in dermatology departments in Spain. Dermatology Online Journal. 22(2). 9 indexed citations
10.
Gagliardi, Dimitri, et al.. (2014). A partial and fragile recovery - Annual Report on European SMEs 2013/2014. Research Explorer (The University of Manchester). 44 indexed citations
11.
Vidal, David, et al.. (2014). Relation au fournisseur : impératif de multicanalité et gestion des émotions. Management & Avenir. N° 72(6). 177–199. 1 indexed citations
12.
Gobbi, Claudio, et al.. (2013). Tercer reporte de eventos adversos con tratamientos biológicos en Argentina. SHILAP Revista de lepidopterología. 24(4). 8–14.
13.
Vidal, David. (2006). Topical Imiquimod: Mechanism of Action and Clinical Applications. Mini-Reviews in Medicinal Chemistry. 6(5). 499–503. 38 indexed citations
14.
Vila, Antonia, L. Puig, María Teresa Fernández‐Figueras, et al.. (2005). Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients. British Journal of Dermatology. 153(2). 417–423. 32 indexed citations
15.
Vidal, David, Xavier Matías‐Guiu, & A. Alomar. (2004). Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Clinical and Experimental Dermatology. 29(5). 518–525. 35 indexed citations
16.
Vidal, David & A. Alomar. (2004). Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients. Clinical and Experimental Dermatology. 29(3). 237–239. 18 indexed citations
17.
Barnadas, María A., et al.. (2002). Simultaneous Presentation of Silicone and Silica Granuloma. Dermatology. 205(2). 162–165. 21 indexed citations
18.
Vidal, David, et al.. (2001). Tuberculous gumma following venepuncture. British Journal of Dermatology. 144(3). 601–603. 9 indexed citations
19.
Vidal, David, Montserrat Gilaberte, R. Taberner, & L. Puig. (2000). Onicomicosis Revisión clínica. 14(4). 84–91. 1 indexed citations
20.
Youlten, L. J. F., et al.. (1999). Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.. PubMed. 27(3). 153–64. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara Valeska Maul Breakdown of academic impact, for papers by Melanie Hagen Breakdown of academic impact, for papers by Elizabeth Quigley Breakdown of academic impact, for papers by Mara Giavina‐Bianchi Breakdown of academic impact, for papers by Yudai Kaneda Breakdown of academic impact, for papers by Hazel Κ. Bell Breakdown of academic impact, for papers by Juliana Berk-Krauss Breakdown of academic impact, for papers by Van C. Willis Breakdown of academic impact, for papers by Pietro Sollena Breakdown of academic impact, for papers by Ana‐Maria Forsea
Rankless by CCL
2026